Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Revisão |
| Idioma: | inglés |
| Publicado: |
2020
|
| Acceso en liña: | https://doi.org/10.1080/14737159.2020.1768849 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|